Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.



Oxford, UK

Infinitopes

Seed

We seek talented teams intent on building businesses that can scale to create or transform an industry. If this describes you, then please get in touch

Job opportunities in the Octopus Ventures portfolio